Jorge A Gomez (Jorge Gómez, J A Gómez, Jorge Gomez, Jorge A Gómez)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 35

Top Topics

Respiratory Syncytial Virus

Psychometric Properties

Top Venues

Human vaccines & immunotherapeutics

Infectious diseases and therapy

Infectious disease reports

Epidemiology and infection

This page only lists publications with an associated author ORCID identifier.

Publications

Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy 13 (4) (2024)
Jorge A Gomez, Otávio Cintra, Arnas Berzanskis, Salma Pacheco, Henny Jaswantlal, Abdelkader El Hasnaoui, Désirée A M van Oorschot, Adriana Guzman-Holst
Burden of Disease Due to Respiratory Syncytial Virus in Adults in Five Middle-Income Countries. Infectious disease reports 16 (4) (2024)
Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy 13 (4) (2024)
Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy 13 (4) (2024)
Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy (2024)
Jorge A Gomez, Otávio Cintra, Arnas Berzanskis, Salma Pacheco, Henny Jaswantlal, Abdelkader El Hasnaoui, Désirée A M van Oorschot, Adriana Guzman-Holst
Burden of Disease Due to Respiratory Syncytial Virus in Adults in Five Middle-Income Countries. Infectious disease reports 16 (4) (2024)
Ahmed Mohy, Youness Lagoubi, Jorge A Gomez, Barry Amadou, Mohammed Bouskraoui
Health economic evaluation of 2-dose and 3-dose rotavirus vaccines in children below 5 years of age in Morocco. Human vaccines & immunotherapeutics 20 (1) (2024)
Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy 13 (4) (2024)
Jorge A Gomez, Otávio Cintra, Arnas Berzanskis, Salma Pacheco, Henny Jaswantlal, Abdelkader El Hasnaoui, Désirée A M van Oorschot, Adriana Guzman-Holst
Burden of Disease Due to Respiratory Syncytial Virus in Adults in Five Middle-Income Countries. Infectious disease reports 16 (4) (2024)
Ahmed Mohy, Youness Lagoubi, Jorge A Gomez, Barry Amadou, Mohammed Bouskraoui
Health economic evaluation of 2-dose and 3-dose rotavirus vaccines in children below 5 years of age in Morocco. Human vaccines & immunotherapeutics 20 (1) (2024)
Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy 13 (4) (2024)
Ahmed Mohy, Youness Lagoubi, Jorge A Gomez, Barry Amadou, Mohammed Bouskraoui
Health economic evaluation of 2-dose and 3-dose rotavirus vaccines in children below 5 years of age in Morocco. Human vaccines & immunotherapeutics 20 (1) (2024)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics 19 (1) (2023)
Jorge A Gomez, F Raul Velázquez, Adriana Guzman-Holst, Maria Yolanda Cervantes Apolinar, Laure-Anne Van Bellinghen, Ilse Van Vlaenderen, Désirée van Oorschot
Cost-effectiveness analysis measuring the total costs against the health benefits of three different rotavirus vaccines for Mexico. Human vaccines & immunotherapeutics (2023)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics 19 (1) (2023)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics (2023)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics 19 (1) (2023)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics 19 (1) (2023)
Adriana Guzmán-Holst, Jorge A Gomez, Otávio Cintra, Désirée A M van Oorschot, Nicolas Jamet, Javier Nieto Guevara
Assessing the Underestimation of Adult Pertussis Disease in Five Latin American Countries. Infectious diseases and therapy (2023)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics 19 (1) (2023)
Sebastian Garcia Marti, Luz Gibbons, Sara Reidel, Juan Andrés Stupka, Juan Ignacio Degiuseppe, Fernando J Argento, Jorge A Gomez
Rotavirus Vaccine Impact since Its Introduction in the National Immunization Program of Argentina. Infectious diseases and therapy 12 (2) (2022)
Youness Lagoubi, Mohamed Tahar Sfar, Jorge A Gomez
A cost-effectiveness analysis of PHiD-CV compared to PCV13 in a national immunization program setting in Tunisia. Human vaccines & immunotherapeutics 18 (5) (2022)
Sebastian Garcia Marti, Luz Gibbons, Sara Reidel, Juan Andrés Stupka, Juan Ignacio Degiuseppe, Fernando J Argento, Jorge A Gomez
Rotavirus Vaccine Impact since Its Introduction in the National Immunization Program of Argentina. Infectious diseases and therapy 12 (2) (2022)
Sebastian Garcia Marti, Luz Gibbons, Sara Reidel, Juan Andrés Stupka, Juan Ignacio Degiuseppe, Fernando J Argento, Jorge A Gomez
Rotavirus Vaccine Impact since Its Introduction in the National Immunization Program of Argentina. Infectious diseases and therapy (2022)
Sebastian Garcia Marti, Luz Gibbons, Sara Reidel, Juan Andrés Stupka, Juan Ignacio Degiuseppe, Fernando J Argento, Jorge A Gomez
Rotavirus Vaccine Impact since Its Introduction in the National Immunization Program of Argentina. Infectious diseases and therapy 12 (2) (2022)
Jorge A Gomez, Javier Nieto Guevara, Josefina C Carlos, Joanne A de Castro, Donald Ray Josue, Edwin Rodriguez
Letter to the Editor Regarding: "Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants". Infectious diseases and therapy 11 (4) (2022)
Jorge A Gomez, Thatiana de Jesus Pereira Pinto, Javier Nieto Guevara, Tatiana Guimarães de Noronha
Response to article by Johnna Perdrizet et al.,"Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants". Human vaccines & immunotherapeutics (2021)
Jorge A Gomez, Diana Caceres, Edisson Rodriguez
Budget impact analysis of pneumococcal conjugate vaccines in Colombia. Response to letter to the editor. Expert review of pharmacoeconomics & outcomes research (2021)
María Gabriela Graña, Gabriel Cavada, Marjorie Vasquez, Jing Shen, Johan Maervoet, Johan Klint, Jorge A Gomez
Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile. Human vaccines & immunotherapeutics (2021)
Ariel Esteban Bardach, Carolina Palermo, Tomás Alconada, Macarena Sandoval, Darío Javier Balan, Javier Nieto Guevara, Jorge A Gomez, Agustín Ciapponi
Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis. PloS one 16 (8) (2021)
Jorge A Gomez, Luz Elena Moreno, Dagna Constenla, Diana Caceres, Edisson Rodriguez
Budget impact analysis of pneumococcal conjugate vaccines in Colombia. Expert review of pharmacoeconomics & outcomes research 21 (2) (2020)
Baudouin Standaert, Christophe Sauboin, Rodrigo DeAntonio, Alen Marijam, Jorge A Gomez, Lijoy Varghese, Sharon Zhang
How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future. Journal of market access & health policy 8 (1) (2020)
Jorge A Gomez, P Wetzler Malbrán, G Vidal, M Seoane, N D Giglio
Estimation of the real burden of invasive meningococcal disease in Argentina. Epidemiology and infection 147 (2019)
Sebastian Garcia Marti, F Augustovski, L Gibbons, V Loggia, A Lepetic, Jorge A Gomez, A Pichón Riviere
Impact assessment of the incorporation of the rotavirus vaccine in the province of San Luis - Argentina. Epidemiology and infection 147 (2019)
Jorge A Gomez, Adriana Guzman Holst, Javier Nieto
Response to article by Matthew Wasserman et al. (2018): "Modeling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico". Human vaccines & immunotherapeutics 15 (3) (2018)